🇺🇸 FDA
Patent

US 7361356

Self-assembling recombinant papillomavirus capsid proteins

granted A61KA61K2039/525A61K2039/5258

Quick answer

US patent 7361356 (Self-assembling recombinant papillomavirus capsid proteins) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2039/525, A61K2039/5258, A61K39/00, A61P